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Abstract
White-nose syndrome (WNS) is the most devastating condition ever reported for hibernating bats, causing widespread
mortality in the northeastern United States. The syndrome is characterized by cutaneous lesions caused by a recently
identified psychrophilic and keratinophylic fungus (Geomyces destructans), depleted fat reserves, atypical behavior, and
damage to wings; however, the proximate cause of mortality is still uncertain. To assess relative levels of
immunocompetence in bats hibernating in WNS-affected sites compared with levels in unaffected bats, we describe
blood plasma complement protein activity in hibernating little brown myotis (Myotis lucifugus) based on microbicidal
competence assays using Escherichia coli, Staphylococcus aureus and Candida albicans. Blood plasma from bats collected
during mid-hibernation at WNS-affected sites had higher bactericidal ability against E. coli and S. aureus, but lower
fungicidal ability against C. albicans when compared with blood plasma from bats collected at unaffected sites. Within
affected sites during mid-hibernation, we observed no difference in microbicidal ability between bats displaying obvious
fungal infections compared to those without. Bactericidal ability against E. coli decreased significantly as hibernation
progressed in bats collected from an affected site. Bactericidal ability against E. coli and fungicidal ability against C. albicans
were positively correlated with body mass index (BMI) during late hibernation. We also compared complement activity
against the three microbes within individuals and found that the ability of blood plasma from hibernating M. lucifugus to
lyse microbial cells differed as follows: E. coli.S. aureus.C. albicans. Overall, bats affected by WNS experience both relatively
elevated and reduced innate immune responses depending on the microbe tested, although the cause of observed
immunological changes remains unknown. Additionally, considerable trade-offs may exist between energy conservation
and immunological responses. Relationships between immune activity and torpor, including associated energy expenditure,
are likely critical components in the development of WNS.
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Introduction
White-nose syndrome (WNS) is the most devastating disease
ever reported for wildlife in North America—with mortality of
hibernating bats approaching 100% at some hibernacula in the
northeastern United States [1,2,3]. This emergent infectious
disease is associated with a newly described psychrophilic and
keratinophylic fungus, Geomyces destructans [4,5]. Bats infected with
G. destructans were first recorded photographically in February
2006 from Howes Cave located approximately 52 km west of
Albany, New York [1]. As of March 2011, presence of G. destructans
in North America has been confirmed in 16 states (Connecticut,
Delaware, Indiana, Maryland, Massachusetts, Missouri, New
Hampshire, New Jersey, New York, North Carolina, Oklahoma,
Pennsylvania, Tennessee, Vermont, Virginia, and West Virginia),
three Canadian provinces (New Brunswick, Ontario, Quebec) and
from nine hibernating bat species. WNS is manifested by some or
all of the following symptoms: 1) a cutaneous fungal infection
appearing as white, filamentous hyphae with distinct conidia
(spores) on the nose, ears, and wing membranes [3,4,5,6]; 2)
depleted white and brown fat reserves [3,7,8] (Jonathan D.
Reichard, unpublished data); 3) ulcerated, necrotic and scarred
wing membranes [9]; and 4) atypical behavior causing bats to
emerge prematurely from hibernacula in mid-winter (Alan C.
Hicks, unpublished data). G. destructans grows on the skin (nose,
ears, and wing membranes) of hibernating bats, and laboratory
research has revealed that it grows optimally at temperatures
characteristic of hibernacula, ranging from 2 to 14uC [3].
Histopathological evidence, the gold standard of infectivity [8],
indicates that the fungus sometimes penetrates the dermis and
underlying connective tissue of hibernating bats especially in areas
associated with sebaceous glands and hair follicles, but does not
appear to elicit an inflammatory immune response. Recently, G.
destructans was isolated from six bat species in Europe [10,11,12];
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other symptoms associated with WNS in North America have not
been reported in Europe. While understanding of the causes and
consequences of WNS is incomplete, over one million bats have
died from this disease with serious ecological and economic
consequences expected, including the predicted extinction of at
least one species within two decades [2].
Although a physiological disruption, changes in environmental
conditions, or a combination of factors may be involved in the
development of the syndrome, recent evidence supports that WNS
is caused by the infectious fungal pathogen G. destructans [5,13].
Thus, it is important to understand levels of immunocompetence
in bats affected with WNS and to describe their potential for
resisting pathogenic or opportunistic fungal infections. Studies
conducted primarily in humans and mice demonstrate that
immunological defense against invading fungi begins, in part,
with the activation of soluble complement proteins resulting in
membrane lysis of foreign cells, increased cell signaling and
adhesion, designation of pathogens for phagocytic killing, a
decreased threshold for B cell activation, an effective proinflam-
matory response, and the clearance of immune complexes and cell
debris [14,15,16,17]. In addition to complement protein activity,
successful immune response against invading fungi includes
inflammatory mechanisms [18], direct antifungal effector func-
tions provided by phagocytic cells (e.g. macrophages, neutrophils,
dendritic cells) [19], T lymphocyte cell-mediated cytotoxicity
[16,17,18,20], and antibody-dependent cellular cytotoxicity
[16,17].
As seasonal hibernators, North American bat species currently
affected by WNS (Myotis lucifugus (Le Conte), M. septentrionalis
(Trouessart), M. sodalis (Miller and Allen), M. leibii (Audubon and
Bachman), Perimyotis subflavus (Cuvier), and Eptesicus fuscus (de
Beauvois) [1,3,4] may experience levels of immunocompetence
constrained by prolonged periods of deep torpor. Although no
published studies have addressed the possible effects of hibernation
specifically on the immune system of free-ranging bats, research in
captive bats [21] and in other hibernating mammals suggest that
deep torpor affects numerous mechanisms associated with
immunity [22,23,24,25,26,27] and experimental studies show that
immunological challenge causes alterations in the length of
interbout arousals [28,29]. Physiological adjustments associated
with deep torpor can result in a decreased primary [30] and
secondary [28,31] humoral response, an absence of T and B
lymphocyte proliferative ability [26], and a decrease in serum
complement protein activity [24]. Torpor can also result in
increased rates of infection [32,33,34] or decreased levels of
infection [30,34,35], presumably depending on optimal growth
conditions of the invading parasite. For example, experimentally
introduced nematodes (Trichinella spiralis) rarely develop into adults
in bats held at 26uC or below. However, although low
temperatures are inhibitory, they are not lethal to the parasite
[36]. It is possible that parasites with similar temperature
requirements may be able to resume normal development when
a torpid host becomes euthermic, either during interbout arousals
or at emergence from hibernation in spring. It is also possible that
pathogens with optimal growth requirements matching conditions
in a torpid bat could thrive by evading host immune responses if
bats, like other mammalian hibernators, experience reduced
immunity during torpor.
We evaluated the innate immune responses of hibernating M.
lucifugus (little brown myotis; Fig. 1) by measuring the activity of
plasma complement proteins using bactericidal assays with
Escherichia coli and Staphyloccocus aureus and a fungicidal assay with
Candida albicans in mid- to late winter 2008 and throughout the
winter of 2008–2009. Using these metrics of relative innate
immune function, we tested the following hypotheses related to
immunocompetence in bats hibernating in WNS-affected sites: (1)
bats hibernating at sites where WNS has not been observed (herein
referred to as unaffected sites) have stronger relative immune
responses compared with bats at WNS-affected sites, where
presence of G. destructans and unusual rates of mortality have been
confirmed; (2) bats with visible cutaneous fungal infections
characteristic of WNS (herein referred to as symptomatic bats)
have weaker relative immune responses compared with bats
without (herein referred to as asymptomatic bats); (3) the ability to
mount an immune response is positively correlated with relative
body condition; and (4) hibernating bats are less capable of
mounting innate immune responses against fungi compared with
gram-negative or gram-positive bacteria. To test these hypotheses,
we measured bactericidal and fungicidal abilities of blood plasma
from M. lucifugus collected at affected sites compared with blood
plasma from M. lucifugus collected at unaffected sites. We also
compared symptomatic with asymptomatic bats within affected
sites and assessed bactericidal and fungicidal abilities across the
hibernation period.
Materials and Methods
Field Sample Collection: Winter 2007–2008
Protocols used for capturing, handling and sample collection
were reviewed and approved by the Boston University Institu-
tional Animal Care and Use Committee (IACUC approval # 08-
022) and followed the United States Fish and Wildlife Service
Disinfection Protocol for Bat Studies. Male and female M. lucifugus
were collected from known affected mines during late hibernation
2008: William’s Hotel, Ulster County, New York on February 12,
2008 (n=6); William’s Lake, Ulster County, New York on
February 13, 2008 (n=28); William’s Preserve, Ulster County,
New York on February 14, 2008 (n=18); and, Chester Mine,
Hampden County, Massachusetts on March 26, 2008 (n=12).
Bats were collected from the unaffected Ely Copper Mine, Orange
County, Vermont on February 26, 2008 (n=21) and Barton Hill
Mine, Albany County, New York on March 25, 2008 (n=18).
All bats were collected by hand from roost substrates and
sacrificed by decapitation. Carcasses were stored at 220uC and
used for other aspects of our research, including body composition
Figure 1. Little brown myotis affected by WNS. Hibernating little
brown myotis (Myotis lucifugus) with and without visible white fungal
growth characteristic of white-nose syndrome.
doi:10.1371/journal.pone.0027430.g001
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ized microcapillary tubes (70 ml capacity), centrifuged for three
minutes using a portable centrifuge (LW Zipocrit, Lawrenceville,
GA) to separate plasma from formed elements, and frozen at
220uC until assayed for complement protein activity. In six bats
from Ely Copper Mine, 12 bats from Chester Mine and six bats
from William’s Preserve Mine, arousal from torpor was stimulated
using chemical heating pads for another aspect of our research.
Body surface temperature was measured using a thermal infrared
camera (Thermacam S-60; FLIR Systems, Inc., Billerica, MA) and
bats were sacrificed at 10 minute intervals starting at 0 minutes
and ending at 50 minutes from initial collection (across all sites,
four bats were sampled at each of the different times). For each
bat, body mass (g), length of forearm (mm), sex, and hematocrit
were recorded. Each bat was also visually examined for signs of the
fungal infection characteristic of WNS, apparent as white,
powdery or filamentous hyphae on the nose, ears, wings, or tail
membrane. Individuals that exhibited obvious signs of fungal
growth were defined as symptomatic. Individuals that did not
exhibit such signs were considered asymptomatic for the purposes
of our comparisons.
Field Sample Collection: Winter 2008–2009
Adult female M. lucifugus were collected from the following
affected sites during the winter of 2008–2009 (See Table 1):
William’s Hole Six Mine, Ulster County, New York on
December 17, 2008 (n=18); Aeolus Cave, Bennington County,
Vermont on 18 November, 2008, 31 January, 2009, and 27
March, 2009 (n=58); Chester Mine, Hampden County, Massa-
chusetts on 20 November, 2008 and 2 February, 2009 (n=37);
Hibernia Mine, Morris County, New Jersey on 13 January, 2009,
and 16 March, 2009 (n=38). Adult female M. lucifugus were
collected from the unaffected CS&M Mine, Lawrence County,
Pennsylvania on 21 January 2009 and 17 March 2009 (n=36)
and the unaffected Jones Adit/Vulcan Mine, Dickinson County,
Michigan on 25 January 2009 (n=19). For the purposes of this
study we considered November and December as early
hibernation, January and February as mid-hibernation, and
March as late hibernation.
Bats were collected by hand from roost substrates and
individually placed in cloth bags. On each sampling date, 18
adult female M. lucifugus were sampled, six each corresponding to
the following rectal temperatures: 1) below 10uC, 2) 10–20uC and
3), above 20uC to test the hypothesis that body (rectal) temperature
affected immune responses for another aspect of our research.
Rectal temperature of individual bats at the time of sacrifice was
included in statistical analyses to control for the effect of this
variable, or was determined to be insignificant before running
nonparametric tests. Arousal from torpor was stimulated using an
electric heating pad and insulated bag. Rectal temperature was
measured using a small thermocouple (Omega HH82A, Stamford,
CT) before and after individuals were sacrificed by decapitation.
When bats reached the desired rectal temperature they were
sacrificed immediately, except in the case of bats sampled near
37uC, which were held for no longer than 30 minutes before
sacrifice. General life-history data were collected, including body
mass (g) and length of forearm (mm) and all bats were visually
inspected for the fungal growth and wing damage characteristic of
WNS [9]. Bats from affected sites were categorized as symptomatic
or asymptomatic as described above. Blood samples were
centrifuged for 3 minutes to separate plasma from formed
elements and hematocrit was recorded. Plasma and red blood
cell fractions were separated and frozen on dry ice or in a dry-
shipper liquid nitrogen dewer during field collection and
transportation, then stored at 280uC until assays were performed.
Carcasses were stored at 280uC and used for body composition
Table 1. Sample sizes for winter 2008–2009 collections across multiple hibernacula and different stages within the hibernation
period.
Hibernacula Location
WNS
Status
Hibernation
Stage Date
Total Sample
Size
Symptomatic
Sample Size
Asymptomatic
Sample Size
Aeolus Cave Dorset County, Vermont affected early 18-Nov 18 0 18
mid 31-Jan 21 15 6
late 27-Mar 19 15 4
William’s Six Mine Ulster County, New York affected early 17-Dec 18 6 12
m i d 000
late 0 0 0
Chester Mine Hampden County, Massachusetts affected early 20-Nov 18 1 16
mid 2-Feb 19 9 10
late 0 0 0
Hibernia Mine Morris County, New Jersey affected early 0 0 0
mid 13-Jan 19 2 16
late 16-Mar 19 16 2
CS&M Mine Lawrence County, Pennsylvania unaffected early 0 na na
mid 21-Jan 18
late 17-Mar 18
Jones Adit/Vulcan Mines Dickinson County, Michigan unaffected early 0 na na
mid 25-Jan 19
late 0
doi:10.1371/journal.pone.0027430.t001
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to assess other aspects of immune function.
Measuring Bactericidal and Fungicidal Ability
Circulating complement protein activity of plasma was tested
using bactericidal and fungicidal competence assays [37] with
Escherichia coli (Microbiologics product # 0483E7; ATCC # 8739),
Staphylococcus aureus (Microbiologics product # 0485 E7; ATCC #
6538), or Candida albicans (Microbiologics product # 0443 E7;
ATCC # 10231). Because samples were frozen prior to assay,
phagocytic activity of immune function cells were not responsible
for killing target microbes using this method, and a validation
using heat-inactivated blood plasma from Eptesicus fuscus demon-
strated that little to no killing occurs as a result of the presence of
heat-stable proteins (M.S. Moore unpublished data). We therefore
considered this assay a measure specifically of complement protein
activity. All samples were assayed within 33 days of collection,
except samples collected from Aeolus Cave, William’s Six Mine
and Chester Mine during early hibernation that exhibited
evidence of contamination upon initial assay and were assayed a
second time within 109 days from sample collection. Sterile
technique was used for all steps in the protocol. Individual
microbes were diluted so that 200–300 colony-forming units were
present in 50 ml of solution and blood plasma was diluted 1:100
using 3 ml plasma in 297 ml 4 mM L-glutamine (Sigma product #
G7513) enriched CO2-independent media (Gibco product #
18045-088). Bacterial or fungal dilutions and plasma dilutions
were mixed 1:15 using 20 ml of microbial dilution and 280 mlo f
plasma dilution. Immediately after mixing, one plate for each
sample was prepared using a 50 ml aliquot of plasma/microbe
mixture spread on tryptic-soy (E. coli, S. aureus) or Sabboraud-
dextrose (C. albicans) agar. After the plasma/microbe mixtures
were incubated for 60 minutes at 23–25uC, a second set of plates
was prepared in triplicate for each sample. Control solutions were
prepared using 70 ml microbial dilution and 980 ml media. Using
50 ml aliquots, six control plates were prepared immediately after
dilution and six plates were prepared after the 60-minute
incubation period. All plates were incubated at 23–25uC for
,24 hours for E. coli, ,48 hours for S. aureus, and ,72 hours for
C. albicans. The number of colony-forming units on each plate was
recorded visually, means of 60-minute experimental plate sets and
0-minute and 60-minute control plate sets were calculated, and the
bactericidal or fungicidal ability of blood plasma was determined
as follows: bactericidal/fungicidal ability
~{1|
60min bloodplate{0min bloodplate
0min bloodplate
|100
 
{
60min controlplate{0min controlplate
0min controlplate
|100
 
The activity of complement proteins within plasma can kill
microbes or inhibit microbial growth resulting in zero or positive
killing values. Killing values can also be negative, reflecting an
inability of plasma components to kill or inhibit microbes as well as
potential microbial division.
Statistical Analyses
All statistical analyses were conducted using SPSS version
16.0.2 (2008; IBM, Armonk, New York) and graphs were
produced using JMP 5.0 (2002; SAS, Carey, North Carolina).
For late winter 2007–2008 data, independent samples t-tests were
used to test for differences in bactericidal ability against E. coli
between bats collected from affected and unaffected sites and to
compare symptomatic with asymptomatic bats within affected sites
(William’s Lake and William’s Preserve only).
For winter 2008–2009 data, bactericidal ability against E. coli
and S. aureus were normally distributed (Shapiro-Wilk’s p.0.25),
but fungicidal ability against C. albicans was not (Shapiro-Wilk’s
p=0.023). Transformations did not improve distribution of the C.
albicans data set, and therefore we used nonparametric statistics.
For the E. coli and S. aureus data sets, we used a parametric mixed
model ANOVA/ANCOVA, testing the following variables for
significance: site, perpetual date, hibernation stage, body temper-
ature, body mass index (BMI; mass (g)/length of forearm (mm)),
number of days between blood sample collection and performing
assays (DTA; 15–109 days for E. coli assays, 16–104 days for S.
aureus assays, and 20–33 days for C. albicans assays), hematocrit,
sites categorized as affected vs. unaffected, and individuals
categorized as symptomatic vs. asymptomatic (from affected sites
only). We also tested for interactions and used a nested design to
test for differences between affected and unaffected sites while
controlling for between site differences. We used Type IV sums of
squares to account for uneven sample sizes between groups and an
unbalanced design with missing treatments (e.g. no bats were
sampled during early hibernation from unaffected sites). Compar-
isons of interest were extracted using simple contrasts and each
contrast was examined for significance. If Levene’s test indicated a
significant departure from equal variance (p,0.05), we used
Brown-Forsythe tests [38] to confirm significance. To further
determine differences and relationships between immune response
and variables included in reduced models, the Tukey method of
post hoc analysis was used. Dependent samples t-tests were used to
test for differences in killing ability of blood against the three
microbes. These comparisons were performed on all available
samples that were tested for killing ability against multiple
microbes regardless of hibernation stage, temperature, site and
presence or absence of WNS symptoms. Mean percent and
standard errors or 95% confidence intervals are presented.
Results
Preliminary Results from Winter 2007–2008: Bactericidal
ability against E. coli
The bactericidal ability against E. coli of blood plasma from bats
collected in late hibernation at the affected William’s Lake and
William’s Preserve sites (18%64%; n=36) was significantly higher
than blood plasma from bats collected also in late hibernation at
the unaffected Ely Copper Mine (4%62%; n=21; Mann-Whitney
U=209; p=0.005). When we compared symptomatic and
asymptomatic bats from the affected sites only, bactericidal ability
of blood plasma from symptomatic bats (10%64%; n=22) was
lower than in asymptomatic bats (25%66%; n=14; Mann-
Whitney U=97; p=0.062), but this difference was not statistically
significant.
Winter 2008–2009: Bactericidal ability against E. coli and
S. aureus and fungicidal ability against C. albicans;
Statistical Models for Whole Data Sets
Results for the bactericidal ability of M. lucifugus blood plasma
against E. coli and S. aureus were normally distributed. The reduced
model, which included hibernation stage, an interaction between
hibernation stage and body mass index (BMI), and number of days
between sample collection and assay (DTA) significantly explained
variation in bactericidal ability of blood plasma against E. coli
across all samples (n=177; F10, 170=13.45; p,0.001; R
2=0.32;
adjusted R
2=0.30). The reduced model including site, hiberna-
tion stage and DTA significantly explained variation in bacteri-
White-Nose Syndrome and Innate Immunity
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samples (n=171; F8, 151=29.03; p,0.001; R
2=0.59; adjusted
R
2=0.57). Results for the fungicidal ability of M. lucifugus blood
plasma against C. albicans were non-normally distributed. Thus,
nonparametric statistics were used to analyze this data set (see
below). Body temperature was not significantly related to any of
the tested microbicidal abilities.
Differences between WNS-affected and unaffected sites
To test the hypothesis that bactericidal ability against E. coli and
S. aureus differs between bats from WNS-affected and unaffected
sites, we used samples only from mid- hibernation because: (1)
hibernation stage was a significant predictor in the reduced
models, (2) high mortality or logistical challenges prevented
collection of samples from all sites during each hibernation stage,
and (3) there was a much smaller range in DTA (15–23 for E. coli
assays and 16–31 for S. aureus assays) during mid-hibernation.
Within the mid-hibernation subset, we found that bactericidal
ability of blood plasma against E. coli was significantly greater in
bats from WNS-affected sites compared with bats from unaffected
sites (affected: 45%62%, n=54; unaffected: 31%63%, n=31; F1,
80=16.22; p,0.001; R
2=0.17; Fig. 2a) after controlling for the
effect of DTA and site. No significant difference in bactericidal
ability against E. coli was observed among individual sites (F3,
80=1.55; p,0.207; R
2=0.06). Bactericidal ability of blood plasma
against S. aureus was also significantly greater in bats collected from
affected sites compared with those from unaffected sites (affected:
23%62%, n=55; unaffected: 29%62%, n=31; F1, 81=9.05;
p=0.004; R
2=0.10; Fig. 2b) after controlling for the effect of
DTA and site. However, within this data set, heterogeneity among
individual sites explained more of the variation in bactericidal
ability than did site type (F3, 81=27.68; p,0.001; R
2=0.51). We
did not detect significant variation in fungicidal ability against C.
albicans across the hibernation period (see below), and therefore
used all available samples (mid- and late hibernation; DTA
range=20–33) to test for differences between site types. Fungicidal
ability against C. albicans was significantly lower in blood plasma
from bats collected at affected sites compared with blood plasma
from bats collected at unaffected sites (affected n=52,
219%64%; unaffected n=25, 7%67%; Mann-Whitney
U=383; p=0.004; Fig. 2c). We also observed significant variation
in fungicidal ability of blood plasma against C. albicans among
individual sites regardless of their WNS status (Kruskal-Wallis
x=17.15; p=0.001).
Comparisons between visibly symptomatic and
asymptomatic bats
The availability of visibly symptomatic and asymptomatic bats
within affected sites varied across the hibernation period, with
more asymptomatic bats being available during early hibernation
and more symptomatic bats available during late hibernation (See
Table 1). Only during mid-hibernation were we able to collect a
roughly equal number of each and thus we used this period to test
for differences between bats with and without visible symptoms of
WNS. When we compared symptomatic with asymptomatic bats
within affected hibernacula we found no difference in the
bactericidal ability of blood plasma against E. coli (symptomatic:
42%64%, n=23; asymptomatic: 48%63%, n=30; F1, 49=1.87;
p,0.178; R
2=0.04). We also found no difference in bactericidal
ability of blood plasma against S. aureus between symptomatic and
asymptomatic bats (symptomatic: 210%64%, n=24; asymptom-
atic: 2%62%, n=30; F1, 50=0.37; p=0.547; R
2=0.01).
Fungicidal ability of blood against C. albicans also did not differ
between symptomatic and asymptomatic bats (symptomatic:
Figure 2. Microbicidal ability of blood plasma from little brown
myotis collected in WNS-affected and unaffected sites. Micro-
bicidal ability, expressed as percent microbe killed, against E. coli (A), S.
aureus (B), and C. albicans (C) in M. lucifugus collected from WNS-
affected and unaffected sites during the winter of 2008–2009.
Significantly more E. coli was killed by plasma collected from bats
hibernating in WNS-affected sites compared with plasma collected from
bats hibernating in unaffected sites (affected n=54; unaffected n=31;
F1, 80=16.22; p,0.001; R
2=0.17). Bactericidal ability against S. aureus
was also significantly greater in bats collected from affected sites
compared with bats from unaffected sites (affected n=55; unaffected
n=31; F1, 81=9.05; p=0.004; R
2=0.10), but fungicidal ability against C.
albicans was significantly lower in bats collected at affected sites
compared with bats collected at unaffected sites (affected n=52;
unaffected n=25; Mann-Whitney U=383; p=0.004). Lines indicate
mean percent microbe killed 61 SE.
doi:10.1371/journal.pone.0027430.g002
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Whitney U=287; p=0.80).
Variation associated with hibernation stage and body
condition
We were only able to acquire samples across the entire
hibernation period from the affected Aeolus Cave and therefore
used this site to test for variation related to hibernation stage (early,
mid, and late). Bactericidal ability of blood plasma against E. coli
varied throughout the hibernation period (early: 58%66%, n=18;
mid: 43%63%, n=17; late: 30%68%, n=16; F2, 48=6.14;
p=0.004; R
2=0.20; Fig. 3a) and was greater during early
hibernation than in late hibernation (p=0.004). Bactericidal
ability of blood plasma against S. aureus also varied significantly
throughout the hibernation period (early: 24%61%, n=18; mid:
219%63%, n=18; late: 8%63%, n=17; F2, 51=31.7; p,0.001;
R
2=0.55; Fig. 3b) and was greater in early hibernation compared
with mid-hibernation (p,0.001), but greater in late hibernation
than in early hibernation (p=0.002) and mid-hibernation
(p,0.001). We did not test blood plasma collected during early
hibernation for fungicidal ability against C. albicans and, for this
reason, did not evaluate variation in this response across the entire
hibernation period. However, fungicidal ability of blood plasma
against C. albicans did not differ between mid- (n=26; 29%64%)
and late hibernation (n=51; 211%66%; Mann-Whitney
U=628; p=0.706).
Because an interaction variable including BMI and hibernation
stage was a significant predictor in the reduced model for the
entire E. coli data set (F3, 166=3
.664; p=0.014; R
2=0.062), we
investigated patterns in BMI across sites and across the
hibernation period. We then tested the relationship between
bactericidal ability of blood plasma against E. coli and BMI within
each hibernation stage. BMI was significantly higher in unaffected
bats compared with affected bats during mid- (affected n=59,
0.1860.01; unaffected n=35, 0.2260.03; F1, 93=79.19; p,0.001)
and late hibernation (affected n=38, 0.1860.01; unaffected
n=18, 0.1960.01; F1, 55=29.13; p,0.001). Controlling for site,
BMI varied throughout the hibernation period in bats from
affected sites (early n=42, 0.2160.02; mid n=59, 0.1860.01; late
n=38, 0.1860.01; F7, 140=25.52; p,0.001; R
2=0.58). Specifi-
cally, BMI was significantly higher in affected bats collected during
early hibernation compared with mid- and late hibernation
(p,0.001), but did not differ between affected bats collected in
mid- and late hibernation (p=0.344). After controlling for site,
BMI did not vary across hibernation stages in bats collected from
unaffected sites (mid: 0.2160.03, n=35; late: 0.1960.01, n=18;
p=0.211).
After controlling for site, BMI was not significantly related to
bactericidal ability against E. coli in early hibernation (F1, 38=0.12;
p=0.745) or mid-hibernation samples (F1, 77=2.87; p=0.094) but
was positively related to BMI in late hibernation samples
(F1, 48=4.47; p=0.04; R
2=0.09; Fig. 4a–c). When we tested this
relationship in bats from affected and unaffected sites separately,
we observed a positive, although non-significant, trend in
bactericidal ability of blood against E. coli during late hibernation
from bats collected at affected sites (n=34; F1, 31=3.24; p=0.082;
R
2=0.10) but not from bats collected at unaffected sites (n=18;
F1, 16=1.19; p=0.291; R
2=0.07). After controlling for site, BMI
did not correlate with bactericidal ability against S. aureus during
any stage of hibernation (Fig. 4d–e). Fungicidal ability of blood
against C. albicans was not associated with BMI during mid-
hibernation, (n=24; Spearman’s r=0.14, p=0.527), but was
positively associated with BMI during late hibernation (n=51;
Spearman’s r=0.29, p=0.039; Fig. 4f,g). In bats from affected
hibernacula, fungicidal ability of blood against C. albicans was
positively correlated with BMI during mid-hibernation (n=18;
Spearman’s r=0.47, p=0.048), but not during late hibernation
(n=34; Spearman’s r=0.04, p=0.808). Blood plasma from bats
collected at unaffected sites showed no association between BMI
and fungicidal ability against C. albicans during mid-hibernation
(n=6; Spearman’s r=20.20, p=0.70) or during late hibernation
(n=17; Spearman’s r=0.11; p=0.68). However, because we were
unable to transform C. albicans data to achieve a normal
distribution, we were unable to test if these relationships were
significant after controlling for site.
Response to different microbes
Mean killing ability of blood plasma from hibernating bats
across all sites and stages of hibernation against the three different
microbes used in this study were as follows: E. coli: 37%62%; S.
Figure 3. Microbicidal ability across the hibernation period.
Microbicidal ability, expressed as percent microbe killed, against E. coli
(A) and S. aureus (B) in blood plasma collected from little brown myotis
hibernating in the affected Aeolus Cave during the 2008–2009
hibernation period. Bactericidal ability of blood plasma against E. coli
varied significantly throughout the hibernation period (early n=18; mid
n=18; late n=16; F2, 49=5.86; p=0.005; R
2=0.19) and was greater
during early hibernation than in late hibernation (p=0.004). Bactericidal
ability of blood plasma against S. aureus also varied significantly
throughout the hibernation period (early n=18; mid n=18; late n=17;
F2, 51=31.7; p,0.001; R
2=0.55), but was greater in early hibernation
compared with mid-hibernation (p,0.001) and greater in late
hibernation than in early hibernation (p=0.002) and mid-hibernation
(p,0.001). Lines indicate mean percent microbe killed 61 SE.
doi:10.1371/journal.pone.0027430.g003
White-Nose Syndrome and Innate Immunity
PLoS ONE | www.plosone.org 6 November 2011 | Volume 6 | Issue 11 | e27430aureus: 22%61%; C. albicans: 210%64%. Blood plasma from M.
lucifugus was significantly better at killing E. coli compared to S.
aureus (n=168; t=18.22; df=167; p,0.001), significantly better at
killing E. coli compared to C. albicans (n=75; Wilcoxon Z=26.59;
p,0.001), and significantly better at killing S. aureus compared to
C. albicans (n=75; Wilcoxon Z=22.94; p=0.003; Fig. 5). There
was a significant positive correlation between bactericidal ability of
blood plasma against S. aureus and fungicidal ability against C.
albicans (Spearman’s r=0.454, p,0.001; Fig. 6).
Discussion
Alterations in innate immune function, as measured by
complement protein activities against gram-negative bacteria (E.
coli), gram-positive bacteria (S. aureus), and fungi (C. albicans) appear
to be associated with the development of WNS in hibernating M.
lucifugus. On average, blood plasma from M. lucifugus hibernating in
WNS-affected sites had significantly greater ability to activate
complement proteins against E. coli compared with blood plasma
from bats hibernating in unaffected sites. Blood plasma from bats
hibernating in WNS-affected sites also had significantly greater
ability to kill S. aureus through complement protein activity
compared with blood plasma from bats collected at unaffected
sites, although differences between sites where bats were collected
accounted for more of the variation in bactericidal ability against
S. aureus than hibernacula type (WNS-affected vs. unaffected). In
contrast to differences in bactericidal abilities, blood plasma from
bats collected from WNS-affected sites was significantly less able to
kill the fungus C. albicans compared with blood plasma from bats
collected at unaffected sites; however, in this case we were unable
Figure 4. Microbicidal ability and body condition. Microbicidal ability, expressed as percent microbe killed, against E. coli (A–C), S. aureus (D–F),
and C. albicans (G, H) in little brown myotis plotted against BMI. After controlling for site, BMI was not significantly related to bactericidal ability
against E. coli in early hibernation (F1, 38=0.12; p=0.745) or mid-hibernation samples (F1, 77=2.87; p=0.094) but was positively related to BMI in late
hibernation samples (F1, 48=4.47; p=0.04; R
2=0.085). After controlling for site, BMI did not correlate with bactericidal ability against S. aureus during
any stage of hibernation. Fungicidal ability of blood against C. albicans was not associated with BMI during mid-hibernation, (n=24; Spearman’s
r=0.14, p=0.527), but was significantly and positively associated with BMI during late hibernation (n=51; Spearman’s r=0.29, p=0.039). Open
diamonds indicate samples collected from bats hibernating in WNS-affected sites and crosses indicate samples collected from bats hibernating in
unaffected sites.
doi:10.1371/journal.pone.0027430.g004
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normal distribution of the C. albicans data set. The observed
differences in microbicidal abilities between bats hibernating at
affected and unaffected sites (specifically during mid-hibernation)
may be explained in at least two ways. First, it is possible that G.
destructans is eliciting an immune response that involves increases in
complement protein production and activity in blood. Increases in
complement protein production and activity in blood may be
particular only for the responses that are also used against E. coli
and S. aureus, or all aspects of complement may be upregulated and
there is some disruption in the activity associated with lysing C.
albicans resulting in the relative decrease in this measure. It is also
possible that blood proteins involved in killing C. albicans were
increased but already activated against G. destructans and therefore
incapable of activating against and lysing C. albicans. Alternatively,
given that preliminary evidence shows that bats hibernating in
affected sites arouse from torpor more frequently compared to
unaffected bats [1], greater use of euthermia may result in
increased circulation of complement proteins [24]. If this were the
sole explanation for altered complement protein activity, it seems
likely that in our experiments we would have observed elevated
fungicidal ability against C. albicans as well. Still, it is possible that
increased use of euthermia resulted in relatively higher levels of
complement proteins in circulation while a disruption or previous
activation reduced the availability of certain complement proteins
in blood to attack C. albicans. Although revealing significant
variation in responses against different microbes between hiber-
nacula types, unfortunately this field-based evidence does not
allow us to differentiate between the possible explanations
presented here. Accordingly, we stress that controlled laborato-
ry-based methods are necessary to determine exactly what
alterations are occurring in response to G. destructans and how
potential changes in torpor patterns contribute to variation in
complement protein activity in the blood of hibernating M.
lucifugus.
Across all microbes used to assess complement protein activity
of blood plasma, there was no difference in microbicidal abilities
between visibly symptomatic compared to asymptomatic bats
within affected sites. One hypothesis for this observation is that
there is no underlying difference in immune function between the
groups and that bats without visible fungal infections may have
been more recently aroused from torpor at which time they
groomed superficial fungus from their skin. We do not know the
recent history of torpor in the free-ranging animals that we
sampled to evaluate whether this is a valid explanation. Addi-
tionally, there may be differences among individuals regarding
development of fungal infections that relate to differences in
immune responses aside from complement protein activity or that
occur during different stages within the hibernation period.
However, because of the disparity in sample sizes between the
two groups within early and late hibernation, we could only test for
differences between these two groups during mid-hibernation.
Again, by monitoring and controlling for variation in use of torpor,
laboratory-based experiments may elucidate potential differences
between individuals in immune parameters that facilitate or inhibit
fungal invasion.
We observed a significant decrease in bactericidal ability of
blood against E. coli as the hibernation season progressed in
samples collected from the affected Aeolus Cave. Bactericidal
ability of blood plasma against S. aureus also varied throughout the
course of hibernation in bats from Aeolus Cave, but was lowest
during mid-hibernation and highest in late hibernation. We did
not test blood plasma for variation in fungicidal ability against C.
albicans across the hibernation period because we were modifying
the killing assay for use with this microbe during early hibernation,
and because we were unable to collect blood from unaffected bats
during early hibernation, we did not test for variation across the
hibernation period in this group. In the case of bactericidal ability
against E. coli, if bats increased production and activity of
complement proteins in response to G. destructans or another
pathogen, this response may have occurred prior to or during early
hibernation and contributed to the observed higher responses in
bactericidal ability against E. coli during early hibernation.
Increased complement protein production and activity in blood
Figure 5. Microbicidal ability against different microbe types.
Microbicidal ability against the three different microbes E. coli, S. aureus
and C. albicans of blood plasma collected from hibernating little brown
myotis across all sites and stages of hibernation. Plasma from M.
lucifugus was significantly better at killing E. coli compared to S. aureus
(n=168; t=18.22; df=167; p,0.001), significantly better at killing E. coli
compared to C. albicans (n=75; Wilcoxon Z=26.59; p,0.001), and
significantly better at killing S. aureus compared to C. albicans (n=75;
Wilcoxon Z=22.94; p=0.003). Lines indicate mean percent microbe
killed and 95% confidence intervals.
doi:10.1371/journal.pone.0027430.g005
Figure 6. Microbicidal ability against a gram-positive bacteria
and a fungus. Correlation between bactericidal ability of plasma
against S. aureus and fungicidal ability of plasma against C. albicans,
both expressed as percent microbe killed (Spearman’s r=0.45,
p,0.001). Open diamonds represent samples collected from little
brown myotis hibernating in WNS-affected sites and crosses represent
samples collected from little brown myotis hibernating in unaffected
sites.
doi:10.1371/journal.pone.0027430.g006
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energy reserves and decreased their capability of maintaining
higher bactericidal abilities against E. coli into mid- and late
hibernation. Alternatively, it is possible that complement proteins
in blood plasma decrease naturally across the hibernation period
because of the extensive use of torpor and overall reduction in
protein synthesis [39]; however, we were unable to test this
hypothesis in unaffected bats due to the rapid spread of the
syndrome during the winter of 2008–2009. Patterns in bactericidal
ability against S. aureus are more challenging to interpret in light of
either hypothesis given the nonlinear change in bactericidal ability
of blood plasma across this hibernation period; however, the range
of proportion bacteria killed was much smaller for S. aureus
(between 244% and 32%) compared with E. coli (between 213%
and 92%) and bactericidal abilities of blood plasma against S.
aureus were more often negative compared with bactericidal
abilities against E. coli. Both of these occurrences may have
reduced our ability to detect biologically meaningful variation
across the hibernation period when using killing assays with S.
aureus. In future studies, the use of more concentrated plasma
samples in S. aureus killing assays may increase variation and help
elucidate potential differences between groups.
This study also demonstrated significant correlations between
complement protein activity of blood plasma against E. coli and C.
albicans and body mass index (BMI) in hibernating M. lucifugus, but
no significant relationships between bactericidal ability against S.
aureus and BMI in the same bats. In tests of the bactericidal ability
of blood plasma against E. coli, where we were able to control for
the differences among sites, we found a positive correlation with
BMI during late hibernation. We also observed a positive
correlation between fungicidal ability of blood plasma against C.
albicans and BMI during late hibernation, but were unable to
control for differences among sites using this method. Little is
known about the energetic costs of immunity or how the immune
system interacts with and depends on metabolic rate and energy
availability [40,41]; however, studies on a number of vertebrate
and invertebrate taxa have demonstrated increased metabolic rate
[42,43,44,45,46] and decreased body mass [44,46,47] during
immunological stimulation. Ots et al. [46] demonstrated that
immune challenge increased basal metabolic rate (BMR) in
wintering great tits (Parus major) injected with the novel antigen
sheep red blood cells (SRBC) and that larger responses against the
antigen, measured as antibody titers against SRBC and changes in
heterophil to lymphocyte ratios, were associated with greater loss
of body mass. Similar increases in BMR have also been observed
in collared doves (Streptopelia decaocto) injected with SRBC [46],
mice injected with keyhole limpet hemocyanin (KLH) [42], and
house sparrows (Passer domesticus) injected with phytohemagglutinin
(PHA) [45]. Bonneaud et al. [47] demonstrated significant body
mass loss related to immune response in house sparrows (Passer
domesticus) injected with lipopolysaccharide derived from E. coli.
Several studies have also shown lower immune response in animals
with reduced fat reserves or reduced energy availability [48,49,50].
Demas et al. [49] demonstrated that experimental reductions in
total body fat reduced the ability of prairie voles (Microtus
ochrogaster) and Siberian hamsters (Phodopus sundorus) to mount
humoral immune responses. Measuring response to PHA
injections in Siberian gerbils (Meriones unguiculatus), Xu and Wang
[50] found that fasting gerbils produced significantly smaller
swellings in comparison to fed gerbils, and that response to PHA
was positively correlated with amount of body fat. Zysling and
Demas [48] experimentally reduced energy availability using 2-
deoxy-D-glucose in long- and short-day Siberian hamsters
(Phodopus sungorus) injected with KLH and observed lower antibody
responses in long-day but not short-day animals. Moreover, in
addition to providing free fatty acids to lymphocytes as fuel [51]
and cell wall components [52], adipocytes are known to secrete
proteins such as leptin, a neuroendocrine signal that indicates
current energy reserve levels to the immune system, and TNF-a,
which mediates inflammatory and cytotoxic immune responses
[40,53,54]. Additionally, the adipose tissue is integral in the innate
production of T helper cell cytokines [55]. These results in
combination support the idea that the immune system is affected
by and dependent on the relative body condition of an individual,
particularly with respect to energy availability, and that immuno-
logical stimulation depletes energy reserves and reduces body
condition.
Results from studies in other taxa parallel the correlations we
observed between immune response and BMI in hibernating M.
lucifugus and support the notion that considerable trade-offs may be
occurring between immune responses and energetics in bats
afflicted with WNS. It is possible that all bats sampled at affected
sites entered hibernation with sufficient energy reserves and
sufficient or even elevated complement proteins in circulation to
maintain a certain level of immunological competence. As the
hibernation season progressed, affected bats used fat reserves to
periodically arouse from torpor, an energetically expensive process
[56] that may have contributed to the decrease in mean BMI from
early to late hibernation. To date, it is unknown why many bats
hibernating in WNS-affected sites experience reduced BMI.
However, preliminary results show that bats hibernating in
WNS-affected sites arouse from torpor more frequently compared
with bats in unaffected sites [1], which would likely cause
premature reductions in energy stores to fuel both arousal and
sustained euthermia. One possibility is that G. destructans elicits
immune responses when bats periodically arouse from torpor,
which would help explain the elevated bactericidal abilities against
E. coli and S. aureus that we observed in our study. This would likely
result in altered interbout arousal periods [28,29], elevated
metabolic rates, and increased fat mobilization and energy
expenditure [42,43,44,45,46]. Alternatively, G. destructans may
simply irritate hibernating bats, which may arouse from torpor
more frequently to groom the fungus from their skin [1]. In any
case, affected bats exhaust reserves of both brown and white
adipose tissue [3]. As energy reserves become diminished, bats
may trade immunity for survival, which would result in individuals
with lower BMI exhibiting reduced immune responses. Once
individuals exhaust stored energy reserves and experience
reductions in immune responses, G. destructans would be able to
invade cutaneous tissue while evading host immune responses.
Final reductions in energy reserves could result in the inability of
bats to arouse from torpor (Jonathan D. Reichard and Marianne
S. Moore, unpublished data) and death.
We observed highly significant differences in the ability of
complement proteins in blood plasma from M. lucifugus to lyse E.
coli, S. aureus, and C. albicans across all samples. These results
demonstrate that hibernating M. lucifugus are less capable of
responding to gram-positive bacteria (S. aureus) than to gram-
negative bacteria (E. coli), and are least capable of responding to a
fungus (C. albicans) through complement activity. It would be
interesting to determine if these differences are broadly applicable
to the ability of bats to respond to these generalized microbe types,
or if specific characteristics of the microbes we used resulted in
greater or lesser complement protein activation.
The use of microbicidal assays presented in this study is one of
many approaches being used to assess relative immune responses
in bats affected by WNS. A multifaceted approach to estimate
levels of immunocompetence is important, given the inherently
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interactions between host, pathogen and environment [58]. In
this study, using three microbes to activate complement proteins
has revealed a variety of relationships that would not be apparent
using a single approach. Results generated to date support the
hypothesis that bats living in affected sites experience reductions in
innate immune responses, particularly against the fungus C.
albicans; however, we also found elevated bactericidal responses in
bats hibernating in affected sites suggesting a more complex
interaction between immune function and the development of
WNS. Our results also show that bats hibernating in WNS-
affected sites experience significant variation in bactericidal ability
across the hibernation period and that M. lucifugus have differing
capabilities of neutralizing pathogens through complement protein
activity in general, with particularly weak activities against fungi.
Our study supports the hypothesis that the physiology of torpor
and the relationship between energetics and immune function may
promote the development of WNS and control the ability of M.
lucifugus and other bat species to resist infection by G. destructans.
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